{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:07:08Z","timestamp":1757628428390,"version":"3.44.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>To evaluate the ganglion cell complex thickness in patients taking oral hydroxychloroquine.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this hospital-based, cross-sectional, non-interventional, comparative study, 87 eyes of 87 patients taking hydroxychloroquine were recruited. All the patients underwent complete ophthalmological evaluation along with dilated fundus examination. Patients were divided into two groups based on the duration of hydroxychloroquine intake: Group 1 (62 patients having duration of hydroxychloroquine intake\u2009&lt;\u20095 years) and Group 2 (25 patients having duration of hydroxychloroquine intake\u2009\u2265\u20095 years). Age and gender-matched healthy volunteers with normal ocular findings were taken as controls. Average, superior, inferior GCC thickness, focal loss volume, and global loss volume were measured by RTvue XR Avanti SD-OCT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The average, superior, and inferior GCC thicknesses were significantly reduced in both Group 1 (&lt;\u20095 years) and Group 2 (\u2265\u20095 years) as compared to controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In Group 1, mean GCC values were 94.70\u2009\u00b1\u20096.34\u00a0\u03bcm (average), 94.43\u2009\u00b1\u20096.28\u00a0\u03bcm (superior), and 94.74\u2009\u00b1\u20096.81\u00a0\u03bcm (inferior), while the corresponding values in controls were 99.79\u2009\u00b1\u20094.61\u00a0\u03bcm, 99.38\u2009\u00b1\u20094.63\u00a0\u03bcm, and 99.97\u2009\u00b1\u20094.61\u00a0\u03bcm. Likewise, FLV and GLV in Group 1 were 1.76\u2009\u00b1\u20092.5% and 4.07\u2009\u00b1\u20093.27%, significantly higher than in controls (0.72\u2009\u00b1\u20090.45% and 1.39\u2009\u00b1\u20091.1%, respectively; <jats:italic>p<\/jats:italic>\u2009=\u20090.002 for FLV, <jats:italic>p<\/jats:italic>\u2009=\u20090.001 for GLV). Similarly, in Group 2, mean GCC thicknesses were 92.70\u2009\u00b1\u20096.39\u00a0\u03bcm (average), 92.44\u2009\u00b1\u20095.92\u00a0\u03bcm (superior), and 93.32\u2009\u00b1\u20097.25\u00a0\u03bcm (inferior), all significantly lower than in controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). While GLV was significantly elevated in Group 2 (4.46\u2009\u00b1\u20094.42%; <jats:italic>p<\/jats:italic>-0.003), the difference in FLV (1.23\u2009\u00b1\u20091.12%) was not statistically significant compared to controls (<jats:italic>p<\/jats:italic>-0.077).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The Ganglion Cell Complex thickness was significantly thinner in patients taking hydroxychloroquine along with elevated Focal Loss Volume % and Global Loss Volume %. However, no statistically significant correlation was observed between GCC thickness and duration of hydroxychloroquine use.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12886-025-04247-w","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:46:06Z","timestamp":1757407566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of ganglion cell complex in patients taking hydroxychloroquine"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3470-5483","authenticated-orcid":false,"given":"Prativa","family":"Acharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragati","family":"Gautam Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-4433","authenticated-orcid":false,"given":"Ranju","family":"Kharel Sitaula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"4247_CR1","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2006.068676","volume":"66","author":"GS Alarcon","year":"2007","unstructured":"Alarcon GS, McGwin G, Bertoli AM, et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007;66:1168\u201372.","journal-title":"Ann Rheum Dis"},{"key":"4247_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:736\u201345.","journal-title":"Ann Rheum Dis"},{"key":"4247_CR3","doi-asserted-by":"crossref","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux\u2010Viala C, Lukas C, Morel J, Hua C. Clinical and structural efficacy of hydroxychloroquine in rheumatoid arthritis: a systematic review. Arthritis care & research. 2020;72(1):36\u201340.","DOI":"10.1002\/acr.23826"},{"key":"4247_CR4","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. American academy of O. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology. 2016;123:1386\u201394.","journal-title":"Ophthalmology"},{"key":"4247_CR5","doi-asserted-by":"crossref","unstructured":"Browning DJ. Hydroxychloroquine and chloroquine retinopathy. New York, NY, USA: Springer; 2014.","DOI":"10.1007\/978-1-4939-0597-3"},{"key":"4247_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/rheumatology\/36.7.799","volume":"36","author":"RI Rynes","year":"1997","unstructured":"Rynes RI. Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol. 1997;36:799\u2013805.","journal-title":"Br J Rheumatol"},{"key":"4247_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10633-005-7349-6","volume":"110","author":"R Tzekov","year":"2005","unstructured":"Tzekov R. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol. 2005;110:111\u201312.","journal-title":"Doc Ophthalmol"},{"issue":"12","key":"4247_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","volume":"132","author":"RB Melles","year":"2014","unstructured":"Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453\u201360.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"4247_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cne.903000103","volume":"300","author":"CA Curcio","year":"1990","unstructured":"Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990;300(1):5\u201325.","journal-title":"J Comp Neurol"},{"key":"4247_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-vision-082114-035502","volume":"1","author":"OS Dhande","year":"2015","unstructured":"Dhande OS, Stafford BK, Lim JH, Huberman AD. Contributions of retinal ganglion cells to subcortical visual processing and behaviors. Annual Rev Vis Sci. 2015;1:291.","journal-title":"Annual Rev Vis Sci"},{"key":"4247_CR11","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1167\/iovs.09-5053","volume":"51","author":"NR Kim","year":"2010","unstructured":"Kim NR, Lee ES, Seong GJ, Kim JH, An HG, Kim CY. Structure function relationship and diagnostic value of macular ganglion cell complex measurement using Fourier-domain OCT in glaucoma. Invest Ophthalmol Vis Sci. 2010;51:4646\u201351.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4247_CR12","first-page":"1158","volume":"17","author":"AR Rosenthal","year":"1978","unstructured":"Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Choroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci. 1978;17:1158\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"4247_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/art.41683","volume":"73","author":"JT Rosenbaum","year":"2021","unstructured":"Rosenbaum JT, Costenbader KH, Desmarais J, Ginzler EM, Fett N, Goodman SM, Marmor MF. American college of rheumatology, American academy of dermatology, rheumatologic dermatology society, and American academy of ophthalmology 2020 joint statement on hydroxychloroquine use with respect to retinal toxicity. Arthritis Rheumatol. 2021;73(6):908\u201311.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"4247_CR14","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1001\/archopht.123.12.1715","volume":"123","author":"TC Chen","year":"2005","unstructured":"Chen TC, Cense B, Pierce MC, Nassif N, Park BH, Yun SH, et al. Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Archives of ophthalmology (Chicago, III: 1960). 2005;123(12):1715\u201320.","journal-title":"Archives of ophthalmology (Chicago, III: 1960)"},{"key":"4247_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/eye.2009.65","volume":"24","author":"S Pasadhika","year":"2010","unstructured":"Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye (Lond). 2010;24:340\u20136.","journal-title":"Eye (Lond)"},{"key":"4247_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/eye.2010.21","volume":"24","author":"S Pasadhika","year":"2010","unstructured":"Pasadhika S, Fishman GA, Choi D, Shahidi M. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity. Eye (Lond). 2010;24:756\u201362.","journal-title":"Eye (Lond)"},{"key":"4247_CR17","first-page":"28","volume":"107","author":"KE Stepien","year":"2009","unstructured":"Stepien KE, Han DP, Schell J, Godara P, Rha J, Carroll J. Spectral-domain optical coherence tomography and adaptive optics May detect hydroxychloroquine retinal toxicity before symptomatic vision loss. Trans Am Ophthalmol Soc. 2009;107:28\u201333.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"4247_CR18","doi-asserted-by":"crossref","unstructured":"Sezgin Akcay BI, Gunay BO, Kardes E, Unlu C, Ergin A. Evaluation of the ganglion cell complex and retinal nerve fiber layer in low, moderate, and high myopia: a study by RTVue spectral domain optical coherence tomography. InSeminars in ophthalmology. Taylor & Francis. 2017;32(6)682\u20138.\u00a0","DOI":"10.3109\/08820538.2016.1170157"},{"issue":"1","key":"4247_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0002-9343(83)91270-6","volume":"75","author":"CL Bell","year":"1983","unstructured":"Bell CL. Hydroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameters. Am J Med. 1983;75(1):46\u201351.","journal-title":"Am J Med"},{"key":"4247_CR20","doi-asserted-by":"crossref","unstructured":"Mahon GJ, Anderson HR, Gardiner TA, McFarlane S, Archer DB, Stitt AW. Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy. Current eye research. 2004;28(4):277\u201384.","DOI":"10.1076\/ceyr.28.4.277.27835"},{"key":"4247_CR21","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s10792-017-0635-y","volume":"38","author":"E Kan","year":"2018","unstructured":"Kan E, Yakar K, Demirag MD, Gok M. Macular ganglion cell\u2013inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine. Int Ophthalmol. 2018;38:1635\u201340.","journal-title":"Int Ophthalmol"},{"issue":"1","key":"4247_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1196\/annals.1351.019","volume":"1069","author":"TK Kvien","year":"2006","unstructured":"Kvien TK, Uhlig T, \u00d8deg\u00e5rd S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci. 2006;1069(1):212\u201322.","journal-title":"Ann N Y Acad Sci"},{"key":"4247_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ajo.2022.07.028","volume":"245","author":"KE Kim","year":"2023","unstructured":"Kim KE, Kim YH, Kim J, Ahn SJ. Macular ganglion cell complex and peripapillary retinal nerve fiber layer thicknesses in hydroxychloroquine retinopathy. Am J Ophthalmol. 2023;245:70\u201380.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4247_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.22631\/rr.2017.69997.1037","volume":"3","author":"M Jokar","year":"2018","unstructured":"Jokar M. Prevalence of inflammatory rheumatic diseases in a rheumatologic outpatient clinic: analysis of 12626 cases. Rheumatol Res. 2018;3(1):21\u20137.","journal-title":"Rheumatol Res"},{"issue":"2","key":"4247_CR25","first-page":"146","volume":"67","author":"SB Agcayazi","year":"2023","unstructured":"Agcayazi SB, Gurlu V, Alacamli G. Decreased perifoveal ganglion cell complex thickness-a first sign for macular damage in patients using hydroxychloroquine. Romanian J Ophthalmol. 2023;67(2):146.","journal-title":"Romanian J Ophthalmol"},{"issue":"1","key":"4247_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5606\/ArchRheumatol.2018.6327","volume":"33","author":"M Bulut","year":"2018","unstructured":"Bulut M, Erol MK, Toslak D, Akidan M, Ba\u015far EK, Cay HF. A new objective parameter in hydroxychloroquine-induced retinal toxicity screening test: macular retinal ganglion cell-inner plexiform layer thickness. Archives Rheumatol. 2018;33(1):52.","journal-title":"Archives Rheumatol"},{"issue":"4","key":"4247_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000517090","volume":"244","author":"MA Sallam","year":"2021","unstructured":"Sallam MA, Beltagi AS, Abdellatif MA, Awadalla MA. Visual impact of early Hydroxychloroquine-Related retinal structural changes in patients with systemic lupus erythematosus. Ophthalmologica. 2021;244(4):301\u20138. https:\/\/doi.org\/10.1159\/000517090.","journal-title":"Ophthalmologica"},{"issue":"1","key":"4247_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1167\/iovs.14-15138","volume":"56","author":"MG Lee","year":"2015","unstructured":"Lee MG, Kim SJ, Ham DI, Kang SW, Kee C, Lee J, Cha HS, Koh EM. Macular retinal ganglion cell\u2013inner plexiform layer thickness in patients on hydroxychloroquine therapy. Investig Ophthalmol Vis Sci. 2015;56(1):396\u2013402.","journal-title":"Investig Ophthalmol Vis Sci"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04247-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:53:42Z","timestamp":1757487222000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04247-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4247"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04247-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the declaration of Helsinki. Approval from the Institutional Review Committee of Institute of Medicine was taken [IRC no: 233 [6\u201311] E2 (080\/081)]. All the participants enrolled in the study were informed in detail about the study. The informed written consent was obtained from all the patient before the start of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was taken from all the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"500"}}